BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
about
ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells.Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
P2860
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
@en
type
label
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
@en
prefLabel
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
@en
P2093
P2860
P356
P1476
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
@en
P2093
Chao-Nan Qian
Chun-Mei Kuang
Qi-Hua Peng
Ran-Yi Liu
Shuai Chen
Wen-di Shuai
Wenlin Huang
Yi-Jun Hua
Yi-Zhuo Li
P2860
P356
10.1038/CDDIS.2017.271
P577
2017-06-15T00:00:00Z